Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7%
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on Thursday reported a decline in adjusted earnings for the first quarter of 2023, despite an increase in revenues. Total revenues moved up 7% year-over-year […]
The post Earnings: Regeneron Pharmaceuticals (REGN) Q1 profit falls; revenue up 7% first appeared on AlphaStreet.